{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:42Z","timestamp":1786993542450,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.juro.2017.01.086","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T01:25:34Z","timestamp":1489109134000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Efficacy of bacillus Calmette-Gu\u00e9rin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis"],"prefix":"10.1097","volume":"198","author":[{"given":"Brock E.","family":"Boehm","sequence":"first","affiliation":[{"name":"Department of Urology, University of Texas Health San Antonio, San Antonio, Texas"},{"name":"Department of Biostatistics (JEC), University of Texas Health San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Cornell","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health San Antonio, San Antonio, Texas"},{"name":"Department of Biostatistics (JEC), University of Texas Health San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health San Antonio, San Antonio, Texas"},{"name":"Department of Biostatistics (JEC), University of Texas Health San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health San Antonio, San Antonio, Texas"},{"name":"Department of Biostatistics (JEC), University of Texas Health San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Oppenheimer","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health San Antonio, San Antonio, Texas"},{"name":"Department of Biostatistics (JEC), University of Texas Health San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Svatek","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health San Antonio, San Antonio, Texas"},{"name":"Department of Biostatistics (JEC), University of Texas Health San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.01.086_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2017.01.086_bib2","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrurol.2013.194","article-title":"BCG immunotherapy for bladder cancer\u2014the effects of substrain differences","volume":"10","author":"Gan","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.juro.2017.01.086_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.1994.tb07548.x","article-title":"Marker tumour response to Evans and Pasteur bacille Calmette-Gu\u00e9rin in multiple recurrent pTa\/pT1 bladder tumours: report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)","volume":"73","author":"Fellows","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1464-410X.1992.tb15486.x","article-title":"Intravesical BCG treatment for superficial bladder cancer: long-term results using two different strains of BCG","volume":"69","author":"Mukherjee","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.eururo.2014.02.061","article-title":"Bacillus Calmette-Gu\u00e9rin strain differences have an impact on clinical outcome in bladder cancer immunotherapy","volume":"66","author":"Rentsch","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.juro.2013.01.084","article-title":"A prospective comparative study of intravesical bacillus Calmette-Gu\u00e9rin therapy with the Tokyo or Connaught strain for nonmuscle invasive bladder cancer","volume":"190","author":"Sengiku","year":"2013","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2017.01.086_bib9","first-page":"10","volume":"14","author":"Witjes","year":"1996","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.juro.2017.01.086_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2017.01.086_bib11","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/pr1006813","article-title":"H-score, a mass accuracy driven rescoring approach for improved peptide identification in modification rich samples","volume":"9","author":"Savitski","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.juro.2017.01.086_bib12","unstructured":"Higgins J and Green S: Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. Available at http:\/\/training.cochrane.org\/handbook. Accessed December 21, 2016."},{"key":"10.1016\/j.juro.2017.01.086_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.juro.2017.01.086_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.juro.2017.01.086_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.juro.2017.01.086_bib16","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2017.01.086_bib17","unstructured":"Dias S, Welton NJ, Sutton AJ et\u00a0al: NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. Available at https:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0088912\/pdf\/PubMedHealth_PMH0088912.pdf. Accessed December 21, 2016."},{"key":"10.1016\/j.juro.2017.01.086_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","article-title":"The treated natural history of high risk superficial bladder cancer: 15-year outcome","volume":"158","author":"Cookson","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.juro.2017.01.086_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.juro.2017.01.086_bib21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/M15-2521","article-title":"Uncertainty in treatment rankings: reanalysis of network meta-analyses of randomized trials","volume":"164","author":"Trinquart","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2017.01.086_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.eururo.2014.11.031","article-title":"Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Gu\u00e9rin","volume":"67","author":"Mostafid","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib23","first-page":"1124","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib24","doi-asserted-by":"crossref","first-page":"484.e19","DOI":"10.1016\/j.urolonc.2016.05.033","article-title":"The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer","volume":"34","author":"Witjes","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2017.01.086_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","article-title":"Final results of an EORTC-GU Cancers Group randomized study of maintenance bacillus Calmette-Gu\u00e9rin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3\u00a0years of maintenance","volume":"63","author":"Oddens","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.01.086_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/1078-0432.CCR-14-1781","article-title":"Sequential intravesical mitomycin plus bacillus Calmette-Gu\u00e9rin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial","volume":"21","author":"Svatek","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717392467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717392467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.01.086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:29:00Z","timestamp":1651192140000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.01.086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1016\/j.juro.2017.01.086"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.01.086","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of bacillus Calmette-Gu\u00e9rin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.01.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}